Carter's (CRI) PT Lowered to $69 at UBS
Tweet
Share
E-mailGet Alerts CRI Hot Sheet
Price: $37.82 -2.32%
Rating Summary:
9 Buy, 11 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
9 Buy, 11 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
UBS analyst Jay Sole lowered the price target on Carter's (NYSE: CRI) to $69.00 (from $101.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- Rakus Co Ltd (3923:JP) PT Raised to JPY1,300 at Macquarie
- Candel Therapeutics Inc. (CADL) PT Raised to $15 at Freedom Broker
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
